Question: A 19-year-old sexually active cisgender woman presents to a student health clinic requesting testing for sexually transmitted infections (STIs). She is asymptomatic. The clinician plans to test this woman for chlamydia using a nucleic acid amplification test (NAAT). Which one of the following statements is TRUE regarding the use of NAATs for the diagnosis of Chlamydia trachomatis infection? NAATs are FDA-cleared for use only on endocervical or urethral specimens NAATs performed on self-collected vaginal swab specimens are equivalent in sensitivity and specificity to those collected by a clinician NAATs are not FDA-cleared for use on liquid-based cytology specimens collected for Pap smears NAATs have decreased sensitivity and specificity compared with culture for detecting chlamydia at rectal sites